[ad_1]
Houston, TX –
Dante Picazo, CHNC’s Chief Executive Officer, said, “The completion of this audit is a significant milestone for our company. We have devoted a great amount of time and attention to this project and believe that our audited financial statements will provide investors with more reliable information about our company and its financial condition.” He added that the company plans to change its corporate name to Cannabis Bioscience International Holdings, Inc. in order to better reflect its core business. The company plans to become an SEC reporting company.
“Despite the ink still being wet, we are more than excited to have completed the audit which represents a management achievement for CHNC. This is the result of hard work from a multidisciplinary team that dedicated all their efforts into this project, and we look forward to the next steps that could be unlocked with this official tool,” said Henry Levinski, the company’s treasurer, who oversaw the audit. He added, “The completion of the audit begins a new chapter for both the company and its investors.”
The company has raised approximately $1.5 million through private placements and believes that its audited financial statements will enhance its ability to raise additional capital in the public and private markets.
We have the energy, the determination and now with our housekeeping matters fully in order, we have no limitations to conquer the global cannabis education market, clinical studies, cannabis clinical trials, university education, and online products.
To learn more visit: https://www.chnc-hdh.com/
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words “may,” “will,” “should,” “plans,” “explores,” “expects,” “anticipates,” “continue,” “estimate,” “projects,” “intends,” and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company’s control.
For more information contact us at:
info@pharmacologyuniversity.com
817/528-2475 for English
214/733-0868 for Spanish
[ad_2]